| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |